Catherine C Turkel - President, Novus Therapeutics, Inc
As of March 20, 2020
Catherine C Turkel Net Worth
- Net worth is estimated to be at least $191.64K
- Owns at least 88,662 units of Novus Therapeutics, Inc stock
- Sold an estimated value of $18.61K in the last 3 years at Novus Therapeutics, Inc
Catherine C Turkel Trading
- Largest purchase of shares was 33,680 units , worth over $161.15K on September 13, 2018
- Largest sale of shares was 9,537 units , worth over $18.61K on May 22, 2019
- In total has made about 10 transactions over 3 years
- Usually trades in September, May and March, with the busiest year in 2018, 2017 and 2019
Catherine C Turkel
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Catherine C Turkel Mailing Address
- Mailing address is 19900 MacArthur Blvd., Suite 550 Irvine CA 92612 CA
Novus Therapeutics, Inc Insider Trading
- The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
- In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
- The most active traders are Catherine C Turkel, President, Gregory J Flesher, Chief Executive Officer, and Jon Kuwahara, See Remarks
- Insider trading is most common in May, with the busiest year in 2019
Eledon Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |